NCT04773301View on ClinicalTrials.gov

Comparative Study Between Levobupivacaine and Ropivacaine in the Hip Fractures of the Elderly

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

February 13, 2021

Primary Completion Date

November 26, 2021

Study Completion Date

December 1, 2021

Conditions
Hip Fractures
Interventions
DRUG

Levobupivacaine

Local anaesthetic drug belonging to the amino amide group. It is the S-enantiomer of bupivacaine

DRUG

Ropivacaine

Local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer.

Trial Locations (1)

37007

Complejo Asistencial Universitario de Salamanca, Salamanca

All Listed Sponsors
collaborator

Instituto de Investigación Biomédica de Salamanca

OTHER

lead

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

OTHER

NCT04773301 - Comparative Study Between Levobupivacaine and Ropivacaine in the Hip Fractures of the Elderly | Biotech Hunter | Biotech Hunter